Bionano Genomics, Inc. (BNGO)

Bionano Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.73	2.99	9.17	17.95	5.09	24.57
Short-Term Investments	6.19	16.28	0.3	48.82	108.1	226.04
Cash & Short-Term Investments	9.92	19.27	9.48	66.77	113.19	250.61
Cash Growth	-39.66%	103.37%	-85.81%	-41.01%	-54.84%	551.80%
Accounts Receivable	4.37	5.2	4.75	9.32	7.02	4.93
Other Receivables	-	0.01	0.02	0.34	0.47	-
Receivables	4.37	5.21	4.77	9.66	7.5	4.93
Inventory	5.2	5.45	11.12	22.89	29.76	12.39
Prepaid Expenses	4.89	0.62	0.7	1.1	1.39	4.48
Other Current Assets	-	14.84	13.42	39.69	5.47	-
Total Current Assets	24.88	45.39	39.49	140.12	157.3	272.41
Property, Plant & Equipment	18.95	21.16	24.32	32.48	28.96	20.94
Goodwill	-	-	-	-	77.29	56.16
Other Intangible Assets	1.67	4.35	9.71	33.97	41.14	26.84
Other Long-Term Assets	2.1	2.69	3.15	7.83	2.81	0.75
Total Assets	47.59	73.58	76.67	214.4	307.5	377.1

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	4.56	5.59	6.96	10.38	12.53	10.77
Accrued Expenses	2.7	4.63	4.62	6.58	9.22	6.94
Short-Term Debt	-	9.98	20.36	69.8	-	-
Current Portion of Leases	0.88	0.95	3.25	2.44	2.55	1.77
Current Income Taxes Payable	0.16	0.27	0.73	1.1	0.83	0.68
Current Unearned Revenue	1.15	0.97	1.13	0.78	0.87	0.68
Other Current Liabilities	0.6	0.56	0.29	8.94	9.89	1
Total Current Liabilities	10.04	22.94	37.34	100.03	35.88	21.84
Long-Term Leases	5.83	5.97	3.68	7.18	9.12	8.93
Long-Term Unearned Revenue	0.12	0.25	0.27	0.15	0.13	0.15
Other Long-Term Liabilities	-	-	-	10.89	12.97	9.07
Total Liabilities	15.99	29.16	41.3	118.25	58.1	39.98

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	-	-	0	0.03
Additional Paid-In Capital	766.94	764.03	728.57	677.34	599.23	553.75
Retained Earnings	-735.35	-719.62	-693.23	-581.21	-348.72	-216.12
Comprehensive Income & Other	0.01	0.02	0.03	0.02	-1.12	-0.54
Total Common Equity	31.61	44.42	35.38	96.16	249.4	337.12
Shareholders' Equity	31.61	44.42	35.38	96.16	249.4	337.12
Total Liabilities & Equity	47.59	73.58	76.67	214.4	307.5	377.1

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	6.7	16.89	27.3	79.41	11.67	10.7
Net Cash (Debt)	3.22	2.38	-17.82	-12.64	101.52	239.92
Net Cash Growth	-	-	-	-	-57.69%	984.42%
Net Cash Per Share	0.34	0.44	-14.02	-22.22	210.61	520.08
Filing Date Shares Outstanding	11.78	11.09	3.01	0.91	0.51	0.48
Total Common Shares Outstanding	11.78	10.74	1.87	0.76	0.5	0.48
Working Capital	14.84	22.44	2.15	40.09	121.41	250.57
Book Value Per Share	2.68	4.14	18.96	126.10	503.52	698.44
Tangible Book Value	29.94	40.08	25.67	62.18	130.97	254.12
Tangible Book Value Per Share	2.54	3.73	13.76	81.55	264.41	526.48
Machinery	39.64	40.16	42.76	38.68	27.11	16.72
Leasehold Improvements	2.51	2.89	3.33	3.75	4	2.67

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 6, 2026

Data Sources Report a data error